Vaalburg W - Search Results

1

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. Kortekaas R, et al. Among authors: vaalburg w. Ann Neurol. 2005 Feb;57(2):176-9. doi: 10.1002/ana.20369. Ann Neurol. 2005. PMID: 15668963

2

An oncological view on the blood-testis barrier.

Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG. Bart J, et al. Among authors: vaalburg w. Lancet Oncol. 2002 Jun;3(6):357-63. doi: 10.1016/s1470-2045(02)00776-3. Lancet Oncol. 2002. PMID: 12107023 Review.

3

Dynamics of multidrug resistance: P-glycoprotein analyses with positron emission tomography.

Hendrikse NH, Vaalburg W. Hendrikse NH, et al. Among authors: vaalburg w. Methods. 2002 Jul;27(3):228-33. doi: 10.1016/s1046-2023(02)00079-8. Methods. 2002. PMID: 12183111

4

Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.

Bart J, Willemsen AT, Groen HJ, van der Graaf WT, Wegman TD, Vaalburg W, de Vries EG, Hendrikse NH. Bart J, et al. Among authors: vaalburg w. Neuroimage. 2003 Nov;20(3):1775-82. doi: 10.1016/s1053-8119(03)00405-1. Neuroimage. 2003. PMID: 14642487

5

PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.

Elsinga PH, Hendrikse NH, Bart J, Vaalburg W, van Waarde A. Elsinga PH, et al. Among authors: vaalburg w. Curr Pharm Des. 2004;10(13):1493-503. doi: 10.2174/1381612043384736. Curr Pharm Des. 2004. PMID: 15134571 Review.

6

Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.

Elsinga PH, Hendrikse NH, Bart J, van Waarde A, Vaalburg W. Elsinga PH, et al. Among authors: vaalburg w. Mol Imaging Biol. 2005 Jan-Feb;7(1):37-44. doi: 10.1007/s11307-005-0951-x. Mol Imaging Biol. 2005. PMID: 15912274 Review.

7

New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics.

Bart J, Dijkers EC, Wegman TD, de Vries EG, van der Graaf WT, Groen HJ, Vaalburg W, Willemsen AT, Hendrikse NH. Bart J, et al. Among authors: vaalburg w. Br J Pharmacol. 2005 Aug;145(8):1045-51. doi: 10.1038/sj.bjp.0706283. Br J Pharmacol. 2005. PMID: 15951832 Free PMC article.

8

In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.

Hendrikse NH, Kuipers F, Meijer C, Havinga R, Bijleveld CM, van der Graaf WT, Vaalburg W, de Vries EG. Hendrikse NH, et al. Among authors: vaalburg w. Cancer Chemother Pharmacol. 2004 Aug;54(2):131-8. doi: 10.1007/s00280-004-0793-2. Epub 2004 Apr 30. Cancer Chemother Pharmacol. 2004. PMID: 15118837

9

Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.

de Vries EF, Kortekaas R, van Waarde A, Dijkstra D, Elsinga PH, Vaalburg W. de Vries EF, et al. Among authors: vaalburg w. J Nucl Med. 2005 Aug;46(8):1384-92. J Nucl Med. 2005. PMID: 16085598 Free article.

10

Positron emission tomography: the conceptual idea using a multidisciplinary approach.

Paans AM, van Waarde A, Elsinga PH, Willemsen AT, Vaalburg W. Paans AM, et al. Among authors: vaalburg w. Methods. 2002 Jul;27(3):195-207. doi: 10.1016/s1046-2023(02)00075-0. Methods. 2002. PMID: 12183107 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters